Company ProfilePremium

Omni Bridgeway Ltd

Company Profile Analysis

Ticker: OBL.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Omni Bridgeway Ltd - Company showcase

Year Founded & Workforce

1986

156 Employees

Omni Bridgeway Ltd logo

Omni Bridgeway Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Omni Bridgeway Ltd Overview

Omni Bridgeway describes itself as the leading global alternative asset manager dedicated to legal assets. Its activities are:

  • originating, underwriting and managing investments in commercial litigation, class/group actions, international arbitration, judgment and award enforcement, and distressed and non-performing asset recovery;

  • doing so across more than 15 countries and both common-law and civil-law systems.

Following the December 2024 to April 2025 Fund 9 continuation-fund transaction with Ares Management, the company changed its capital model. It moved from a balance-sheet-heavy, net-debt-funded co-investor to a capital-light fund manager. It now earns management, transaction and service fees and carried interest on third-party capital, while retaining co-investment exposure. At 30 June 2026 it was debt-free at the corporate level, managed A$5.9bn of AUM and held interests in more than 300 active litigation investments.

Its competitive claim rests on three things: a 40-year realised track record (FY26 MOIC 2.3x; five-year trailing IRR 40%), unusual jurisdictional breadth, and an enforcement and asset-recovery capability few funders possess. The core investment debate is converting this platform into durable, fee-covered, per-share earnings growth.


Company's own description (FY26 Annual Report)

The FY26 Annual Report defines the Group's principal activities as "the management of, and co-investment into funds or other investment structures that are focused on legal finance and the investment in legal assets globally."

The Group invests through four types of agreement:

  • financing,

  • purchase,

  • monetisation, or

  • risk-sharing.

Its counterparties are claimants, liquidators, banks, creditors and law firms, in relation to legal claims, awards, judgments and non-performing loans, either standalone or on a portfolio basis. Overlaying this is an asset-management layer that services third-party capital, generates management, service and transaction fees, and provides carried-interest upside.

The report names three core operations:

  1. Litigation and Arbitration Funding. Capital provided to claimants and law firms for high-value commercial disputes, class actions and international arbitrations. Returns depend on settlement, judgment or award.

  2. Legal Enforcement and Asset Recovery. Funding the enforcement and/or monetisation of claims, judgments and awards, especially cross-border. This includes distressed and non-performing assets.

  3. Investment Management. Acting as investment adviser to multiple funds and structures, earning:

    • transaction fees (e.g., Funds 4/5 Series II),

    • management fees (all funds except Fund 1 and Funds 2&3), and

    • carried interest (Funds 6 and Funds 4/5 Series I and II).

Revenue model

Revenue streamNatureTemplate analogueFY26 evidence (source)
Investment proceeds / fair-value gains on co-investmentsPrincipal investment returns. These are lumpy and outcome-contingent; typically the investment plus a multiple of capital or a % of recovery, often escalating with duration.Closest to "product" or principal incomeNet gain on litigation investments (financial assets) A$61.9m; gross proceeds and investment revenue A$105.6m (FY26 AR)
Management feesRecurring fees on net deployed or committed third-party capital, recognised quarterly in arrearsClosest to "subscription"Management fees A$35.4m (FY26 4Q report); management fee cash proceeds A$28.8m (FY26 AR cash flow)
Transaction and service feesUnderwriting and monitoring fees (e.g., Funds 4/5 Series II)ServiceIncluded in "management, service and transaction fees" of A$27.3m statutory revenue (FY26 AR Note 2)
Carried interestProfit share above fund hurdles; American-waterfall funds pay earlierPerformance feeCash carried interest A$6.6m (FY26 4Q report)
Claims-portfolio enforcement revenuePercentage-of-recovery fees on enforcement and recovery services (largely EMEA)Service (success-fee)A$69.0m (FY26 AR Note 2)
Interest revenueMainly on purchased claimsFinancialA$10.2m (FY26 AR Note 3)

The template's product/service/subscription/licensing split maps onto Omni Bridgeway's economics as follows:

Analyst characterisation. On FY26 numbers, OBL is a hybrid. It is roughly 25–35% a fee-earning manager, measured by fee income relative to total statutory income. The remainder is an outcome-contingent principal investor. Management's stated objective is to raise the fee share: cost coverage, defined as fee income over cash operating expenses, rose from 36% in FY25 to 53% in FY26. Management has signalled a 70% cost-coverage target by 2028 (1H26 results commentary as reported by investing.com). The model is "capital-light" in that most new deployments are funded by third parties: OBL-only deployments were A$28.3m of A$241.8m total in FY26, about 12%.

Value-chain position, customer types and end-markets

OBL sits between capital providers and legal-claim owners:

Capital providers: include institutional LPs, Ares (Fund 9), insurers providing ATE and capital-protection wrap, and sidecar investors.

Claim owners: include corporates, insolvency practitioners, law firms, class members, sovereign creditors and banks holding NPLs.

The company's website identifies three client groups: law firms (portfolio and firm-level financing), companies (single-case and portfolio monetisation) and bankruptcy/insolvency professionals.

End-markets served:

  • commercial disputes,

  • international arbitration (including investor-state),

  • intellectual property (US patent),

  • investor recoveries and securities class actions (non-US group actions),

  • appeals,

  • whistleblower claims,

  • bankruptcy,

  • judgment enforcement, and

  • distressed asset recovery (company website "Solutions" taxonomy).

Independent characterisation. The economic engine is underwriting skill (probability, duration, budget, quantum and recoverability), combined with a fund structure that monetises that skill on others' capital. The key sensitivities are:

  • duration, which dilutes IRRs;

  • FX, since most assets are USD/EUR-denominated against an AUD reporting currency (FY26 OCI loss A$48.7m); and

  • realisation timing, which management explicitly declines to forecast.

Strategy

Stated strategy (themes from FY25–FY26 reporting)

Management summarises the arc as "FY25 was a year of transformation, FY26 was a year of execution." The FY26 Remuneration Report and results materials articulate four strategic priorities:

  1. Improving cost coverage: growing fee income relative to cash opex.

  2. Expanding and diversifying the legal-assets portfolio: record A$712.2m of commitments in FY26.

  3. Maintaining strong investment performance: MOIC 2.3x, fair-value conversion 105%, five-year trailing IRR 40%.

  4. Broadening third-party capital sources: flagship funds, continuation funds, sidecars and structured solutions.

The positioning theme is that the industry is "consolidating around a small number of institutional-grade platforms." Management argues that a four-decade track record is the hardest asset to replicate (CEO, FY26 release).

Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDescriptionTargets / outcome
Fund 9 continuation fund with AresDec 2024 – Apr 2025Sale of 70% of co-investments in 150+ assets~A$320m cash; debt repaid; ~A$30m annual interest saved (ShareCafe)
Capital-light transition and deconsolidationFY25Reporting aligned with asset-management peers; deconsolidation of Funds 2&3 and Fund 4 Series I&IICompleted
Capital formation teamMar 2025Dedicated team coordinating fund raisingUS$1bn Funds 4/5 Series II target reached in Aug 2026
Opex reduction programmeFY25–FY26FY25 target A$85m; FY26 budget A$80mFY26 actual A$67.1m (16% under budget)
Fee income targetsFY26FY26 target A$35m (upgraded)A$35.4m achieved
Cost coverage targetDisclosed 1H2670% cost coverage by 2028 (investing.com summary of 1H26 results)FY26: 53%
Sidecar and structured capitalFY26Fee-paying sidecars; structured solutionsA$72.5m raised; ~A$175m in diligence
Head of Commercial Strategy & Capital SolutionsApr 2026New York-based role for large structured financingsHire completed
Introduction to Omni Bridgeway and Analyst Data Pack26 Mar 2026Enhanced transparency for analystsReleased
Team Carried Interest PlanFY26Carry-based remuneration replacing STI/LTI for investment staff84 participants
Executive PlanAGM Oct 2026Performance rights with TSR, ROE and AUM-growth hurdlesSubject to shareholder vote
AI-driven efficiencies1H26 commentaryReferenced in the 1H26 call summary as supporting the outlookNo quantified target disclosed

Medium-term targets and guidance

TargetCurrent position
70% cost coverage by 202853% in FY26
Continued fee-income growth as AUM scalesFee income +17% in FY26
Opex discipline—
Executive Plan ROE hurdle12.5–17.5%
Executive Plan AUM growth hurdle5–12.5% a year

The company does not provide earnings forecasts because completion timing is uncertain (FY26 AR, "Likely developments"). Quarterly reports instead give indications of completion values and estimated new commitments.

Explicit or implied operating targets:

ESG and sustainability: no quantified commitments were found.

Products & Services

Omni Bridgeway has no physical products, patents-as-products or software platforms. Its "products" are financing solutions and fund vehicles. Pricing is negotiated case by case: typically a multiple of capital deployed, a percentage of proceeds, or the greater of the two, usually escalating with duration (FY26 AR). Specific price grids are not publicly disclosed.

Financing solutions (client-facing)

SolutionDescription and capabilitiesTarget customerPricing modelStatus
Dispute Funding – CommercialNon-recourse funding of fees and costs for high-value commercial claims; single-case or portfolioCorporates, claimants, law firmsMultiple and/or % of proceeds; escalatorsCore, all regions
Dispute Funding – Intellectual PropertyPatent and IP litigation funding, mainly USPatent owners, IP firmsAs aboveChambers Band 1 US IP (2025)
Dispute Funding – Investor RecoveriesSecurities and investor loss claimsInstitutional and retail investorsAs aboveActive
Dispute Funding – Class/Group Actions (non-US)Australian, Canadian, NZ, European group actions. Funding commission is often court-supervised; adverse-cost cover is provided.Class members, plaintiff firmsCourt-approved commissionAPAC flagship (e.g., co-funding of Medibank data-breach class action, BHP and Rio Tinto discrimination actions, and an ESSSuper entitlements action per Business News Australia, Apr 2025)
Dispute Funding – AppealsFunding of appellate stages; may include monetisation of judgments under appealJudgment holdersMultiple / discountActive
Dispute Funding – WhistleblowerFunding of whistleblower claims (e.g., qui tam)Whistleblowers and counsel% of recoveryActive
Dispute Funding – BankruptcyFunding for trustees and liquidators to pursue estate claimsInsolvency professionals% of recoveryHeritage IMF franchise
Arbitration FinancingCommercial and investor-state arbitration funding, including award monetisationCorporates, sovereign creditorsAs aboveChambers Band 1 International Arbitration (2020–2025)
Judgment EnforcementFunding and running enforcement of judgments and awards, including against sovereigns; asset tracing and intelligenceAward and judgment creditors, ECAs, insurersSuccess fee / purchaseChambers Band 1 Global Asset Tracing & Recovery (2020–2025)
Distressed Asset RecoveryNPL enforcement, subrogation claims for insurers, purchased claims. Includes the IFC JV (DARP).Banks, insurers, multilateralsPurchase price discount / % of recoveryEMEA-led
Law Firm FinancingPortfolio and firm-level facilitiesLaw firmsPortfolio termsActive
Adverse-cost cover / ATE capabilityCoverage of client adverse-cost exposure in loser-pays jurisdictions, using insuranceClaimants in AU, UK, EU, CAEmbedded in funding termsActive
Structured finance and alternative investment solutionsLarge-scale structured legal-asset financings and sidecars; led from New York by Peter Galgay since April 2026Institutional investors and large claim holdersBespokeNew initiative; A$72.5m sidecar capital raised in FY26, ~A$175m in diligence

Fund and investment vehicles (investor-facing)

VehicleDescriptionFees to OBLKey disclosed factsStatus
Fund 1US-focused legacy fundNo management fee (FY26 AR)Size not re-verifiedHarvesting
Funds 2 & 3Legacy APAC/RoW fundsNo management feeOBL co-investment sold into Fund 9; deconsolidated FY25Harvesting
Funds 4/5 Series IGlobal flagship seriesManagement fees; carried interestOBL co-investment sold into Fund 9; Fund 4 Series I deconsolidated FY25Harvesting
Funds 4/5 Series IICurrent global flagshipTransaction fees; management fees; carried interestUS$1bn raise target achieved post-FY26. Includes >US$300m of subscriptions on substantially agreed terms pending documentation. US$228m closed in 1H26.Investing
Fund 6Fund with carried interest to OBLManagement fees; carried interestSize not re-verifiedInvesting/harvesting
Fund 8Enforcement-focused fund (target €300m) using insured, non-recourse debtManagement feesFirst tranche €135m (Sep 2023). Facility non-recourse to OBL beyond insurance, Fund 8 assets and a capped standby equity commitment. A$35.4m borrowings consolidated at 30 June 2026.Investing
Fund 9 (Continuation Fund)First continuation fund for legal assets. Holds OBL's former co-investments in 150+ assets. Ares 70%, OBL 30%.Management fees (FY25 3Q report referenced fee arrangements); Ares has a preferred return~A$320m paid to OBL for Ares' 70%Harvesting
SidecarsFee-paying co-investment vehicles alongside fundsSeparately agreed management fees and carried interestA$72.5m raised FY26Growing
DARP (with IFC)JV programme for NPL enforcement in emerging markets——Active (status not re-verified)

Financial Narrative

How to read OBL's financials

Three accounting features make conventional metrics unreliable:

  1. Fund consolidation. Fund consolidation, and the FY25 deconsolidation, produce large non-controlling interests (NCI). "Profit for the year" therefore differs from "profit attributable to members". FY26: A$45.9m versus A$53.7m.

  2. Mixed measurement. Litigation investments are carried partly at fair value through profit or loss (12% discount rate; FY26 AR) and partly at cost, as intangible assets or claims portfolio. Statutory "revenue" therefore excludes most investment returns.

  3. Third-party definitions. S&P Global's standardised "revenue", "gross profit" and "operating income" do not correspond to company definitions and should be read as indicative only.

Company-reported figures are used wherever available and labelled; S&P-standardised figures are labelled "S&P".

Company-defined income metrics (FY24–FY26)

FY24 values are back-calculated from the reported FY25 percentage changes: total income +253%, profit +1267%, revenue -18%. FY24 NCI is derived as profit after tax less attributable loss.

Margins (S&P definitions; indicative only)

Revenue CAGR. On S&P-standardised revenue, the FY22–FY26 CAGR is ≈37.9% (A$31.0m to A$112.3m). This is not economically meaningful, because "revenue" excludes most investment returns. A more meaningful growth metric is fee income: A$25m (FY24) to A$35.4m (FY26), a ≈19% two-year CAGR.

Margin commentary. Net margin on total income is a better gauge than S&P margins:

  • FY26: 25.2% (A$45.9m / A$182.2m)

  • FY25: 64.0%, distorted by Fund 9

  • FY24: ≈16.5%

The structural improvement is on the cost side:

  • Employee costs fell A$10.0m.

  • Professional fees fell from A$11.3m to A$4.4m, as FY25 Fund 9 deal costs did not recur.

  • Finance costs fell from A$11.1m to A$1.3m after debt repayment.

Balance sheet

Sources and notes:

  • FY25–FY26 are from the FY26 AR. FY22–FY24 are from S&P Global via StockAnalysis.

  • FY22 borrowings were classified as current, as the facility was maturing.

  • FY26 is presented on an unclassified basis in the statutory accounts, so the short/long split is not available. The company's working-capital analysis gives current assets of A$224.4m and current liabilities of A$131.9m.

Litigation investments carrying value: A$652.0m at 30 June 2026 versus A$628.1m at FY25. The FY26 breakdown is:

  • financial assets at FVTPL: A$473.0m

  • claims portfolio: A$90.4m

  • intangible assets: A$62.0m

  • purchased claims: A$26.6m

  • investment in associates: A$1.1m

Other notable liabilities (FY26):

  • Fund 9 warrants liability: A$29.5m (FY25: A$22.9m). Management expects equity settlement.

  • Deferred tax liabilities: A$86.5m, including A$75.3m relating to the Fund 9 transaction.

  • Provisions fell from A$33.1m to A$5.4m.

Cash flow

Sources: FY25–FY26 from the FY26 AR; FY22–FY24 from S&P Global.

Buybacks:

  • FY25: A$10k paid under a share buy-back scheme (FY26 AR comparative).

  • FY26: nil.

Cash flow commentary. IFRS classification splits litigation cash flows between operating (claims portfolio) and investing (intangibles, purchased claims, financial assets). OCF and FCF in the conventional sense therefore materially understate economic cash generation. The FY26 aggregate operating plus investing flows included:

  • proceeds from litigation investments: A$138.0m

  • management-fee proceeds: A$28.8m

  • payments for litigation investments: A$80.0m

Management's "OBL-only net cash generation" was +A$22.4m in FY26. Financing flows were near-neutral (-A$0.3m), comprising:

  • A$19.0m Fund 8 drawdown,

  • A$11.2m distributions to NCI, and

  • A$5.2m lease payments.

FY25 financing flows of -A$273.7m reflected the A$250m debt repayment funded by Fund 9 (investing inflow of A$314.1m from disposal of subsidiaries).

Ratios (analyst calculations unless noted)

Notes and other ratios:

Company-defined returns: On pre-NCI NPAT over average equity (company definition, FY26 AR), ROE was 5.3% in FY26 and 50.3% in FY25; ROA was 4.0% and 34.4%. A third-party summary (Quartr) reports FY26 ROE of 8%, consistent with the attributable-basis calculation above.

ROIC: 0.23% on S&P's definition (FY26). Not meaningful for this model.

Interest coverage: (PBT + finance costs) / finance costs was ≈37.5x in FY26 and ≈45.6x in FY25. S&P reports 2.33x on its operating-income basis.

Net debt/EBITDA: Not meaningful (net cash) for FY25–FY26. FY24 net debt was A$135.9m against S&P EBITDA of A$26.1m, about 5.2x.

Asset turnover: 0.10x (S&P, FY26).

Cash conversion cycle: Not applicable (no inventory or trade-receivable cycle in the industrial sense).

Critical observation on book value per share. The company's headline "net assets per share" (A$2.96 FY26; A$2.99 FY25) equals total equity including NCI divided by shares on issue. Equity attributable to OBL shareholders is A$676.6m, or about A$2.34 per share. The company also reports:

  • "book value of investments per share": A$2.25 (FY25: A$2.18)

  • "NTA per share": A$2.08 (FY25: A$1.94)

The 1H26 release cited "total book value per share" of A$3.20, which is a non-IFRS metric including off-balance-sheet fair values. Investors comparing price to book should be explicit about which measure is used.

Operating KPIs (company, non-IFRS)

FY24 fee income is as cited in the FY25 release ("from A$25m to A$30m"). FY24 AUM is derived from the stated "14% CAGR since FY24" and is approximate.

FY25 opex is derived from "20% below FY25". FY25 commitments are derived from "+38%". FY25 new fair value is derived from "+A$38.5m".

Other FY26 KPIs:

  • 80 completions at 2.3x MOIC and a 105% fair-value conversion ratio

  • deployments A$241.8m (OBL-only A$28.3m)

  • OBL-only cash and receivables A$124.5m

  • OBL-only EBIT A$49.4m

  • pipeline of 43 exclusive term sheets worth an estimated A$407.8m

  • a further A$45.3m of proceeds received after 30 June 2026 at an estimated 5.7x MOIC (4Q26 report)

Trend and inflection commentary

FY22–FY24: the balance-sheet era. Statutory losses accumulated (A$-45.7m, A$-31.7m, A$-87.5m attributable). Net debt rose from A$3m to A$136m as OBL co-funded its own funds with borrowed money. Attributable book value per share fell to A$0.89. The market cap fell from roughly A$1bn (Simply Wall St, May 2022: A$954m) to under A$300m by late 2024.

FY25: the inflection. Fund 9 crystallised legacy fair value at more than 3x MOIC. Debt was repaid, the funds were deconsolidated, NCI shrank from A$544m to A$194m, and attributable equity rose 167%.

FY26: a normalised year. It showed operating leverage (opex -20%, fees +17%) and record activity. Statutory profit, however, depended on fair-value gains. On implied figures, 2H26 posted a statutory loss before NCI of ≈A$38.6m (FY A$45.9m less 1H A$84.5m). A A$42.8m FX translation loss in OCI also trimmed equity. Fee-only economics still do not cover the cost base, though the gap is narrowing.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

MetricFY2025FY2026

Americas segment revenue (AUD Mn)

711

APAC segment revenue (AUD Mn)

11710

EMEA segment revenue (AUD Mn)

6895

Corporate segment revenue (AUD Mn)

-1652

Total segment revenue (AUD Mn)

27118

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment

MetricFY2025FY2026

Americas total segment income (AUD Mn)

2039

APAC total segment income (AUD Mn)

49583

EMEA total segment income (AUD Mn)

180147

Corporate total segment income (AUD Mn)

-2182

Group total segment income (AUD Mn)

660241

Results by Segment — Americas fair value gain or loss

MetricFY2025FY2026

Americas fair value gain or loss (AUD Mn)

-255

APAC fair value gain or loss (AUD Mn)

4979

EMEA fair value gain or loss (AUD Mn)

31106

Group fair value gain (AUD Mn)

55280

Results by Segment — Americas EBITDA

MetricFY2025FY2026

Americas EBITDA (AUD Mn)

188-25

APAC EBITDA (AUD Mn)

46067

EMEA EBITDA (AUD Mn)

12775

Corporate EBITDA (AUD Mn)

-240-29

Group EBITDA (AUD Mn)

53588

Results by Segment — Americas profit before tax

MetricFY2025FY2026

Americas profit before tax (AUD Mn)

185-27

APAC profit before tax (AUD Mn)

45866

EMEA profit before tax (AUD Mn)

10338

Corporate profit before tax (AUD Mn)

-250-29

Group profit before tax (AUD Mn)

49648

Revenue by Segment — Americas operating expenses

MetricFY2025FY2026

Americas operating expenses (AUD Mn)

819

APAC operating expenses (AUD Mn)

1815

EMEA operating expenses (AUD Mn)

1517

Corporate operating expenses (AUD Mn)

2520

Segment Revenue

SegmentFY26 share of total segment incomeFY26 PBT margin on segment incomeYoY change in segment income

Americas

3.7%

n/m (loss of A$27m on A$9m income)

-96%

APAC

34.4%79.5%-83%

EMEA

61.0%25.9%-18%

Corporate

0.8%

n/m

n/m

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue S&P standardised (AUD Mn)

31.0321.5061.0587.77112.26

Gross profit S&P (AUD Mn)

-25.94-49.511.3430.4564.08

Operating income S&P (AUD Mn)

-60.85-93.09-47.35-25.521.78

EBITDA S&P (AUD Mn)

8.846.6826.07533.6637.30

Profit before tax (AUD Mn)

-1.79-3.819.51495.5248.17

Net profit attributable to members (AUD Mn)

-45.65-31.66-87.52349.8053.70

Basic EPS (AUD)

-0.17-0.12-0.311.23150.1858

Diluted EPS (AUD)

-0.17-0.12-0.311.22570.1846

Dividends per share (AUD)

00000

Income Statement

MetricFY2024FY2025FY2026

Total income statutory (AUD Mn)

184.5651.2182.2

Profit after tax before NCI (AUD Mn)

30.5416.845.9

Profit attributable to NCI (AUD Mn)

118.067.0-7.8

Revenue from ordinary activities per Appendix 4E definition (AUD Mn)

82.968.0106.5

Financial Analysis

Line itemAUD K

Revenue from contracts with customers

96,312

Interest revenue

10,156

Net gain on litigation investments (financial assets)

61,920

Net gain on derecognition (intangibles)

7,037

Net gain on purchased claims

5,566

Share of associates

222

Other income

1,022

Total income

182,235

Finance costs

1,322

Amortisation of claims portfolio

35,073

Depreciation

4,012

Employee benefits

51,160 (down 16%)

Corporate and office

13,541 (down 35%)

Other

7,917

Impairment and adverse costs

12,733

Expected credit loss

1,646

Fair-value adjustment on warrants

6,660

Profit before tax

48,171

Income Statement (FY2025–FY2026)

MetricFY2025FY2026

Litigation investment proceeds (AUD Mn)

235.5350.5

Proceeds from secondary market transactions (AUD Mn)

294.70

Management fees (AUD Mn)

30.335.4

Interest revenue and other (AUD Mn)

33.22.4

Total gross revenue (AUD Mn)

593.7388.3

Less third party interest (AUD Mn)

-106.8-244.9

Platform expenses (AUD Mn)

-85.9-72.6

Litigation costs (AUD Mn)

-58.5-47.8

Profit before tax consolidated (AUD Mn)

495.548.2

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin S&P (%)

-83.61-230.312.1934.7057.08

Operating margin S&P (%)

-196.13-433.03-77.56-29.081.58

EBITDA margin S&P (%)

28.531.142.7608.033.2

Pretax margin S&P (%)

-5.78-17.7315.58564.5942.91

Net margin S&P (%)

-147.12-147.27-143.37398.5647.83

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (AUD Mn)

1,075.01,135.01,237.01,185.91,122.5

Cash and equivalents (AUD Mn)

158.97117.02135.88180.29158.61

Borrowings excluding leases (AUD Mn)

148.00181.64254.8119.5035.40

Lease liabilities (AUD Mn)

13.9317.9416.9813.039.89

Total debt including leases (AUD Mn)

161.93199.58271.8032.5345.29

Net cash or net debt (AUD Mn)

-2.96-82.56-135.92147.76113.32

Goodwill (AUD Mn)

95.57103.30100.89112.91104.41

Equity attributable to members (AUD Mn)

328.89348.85250.72668.59676.64

Non-controlling interests (AUD Mn)

410.61435.44544.21194.20181.95

Total equity (AUD Mn)

739.50784.29794.93862.78858.59

Net working capital (AUD Mn)

16.75163.00138.15111.8292.53

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (AUD Mn)

-74.55-130.43-87.8817.09-18.34

Capital expenditure (AUD Mn)

-1.85-0.73-0.09-0.04-0.13

Free cash flow (AUD Mn)

-76.40-131.16-87.9617.05-18.48

Dividends paid (AUD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE on attributable equity (%)

-13.82-9.34-29.1976.107.98

ROA attributable NPAT over average total assets (%)

-4.26-2.87-7.3828.874.65

Current ratio (x)

1.062.572.071.711.70

Total debt to total equity (x)

0.220.250.340.040.05

Attributable book value per share (AUD)

1.221.250.892.322.34

Net assets per share including NCI (AUD)

2.752.812.812.992.96

Key Financials

MetricFY2024FY2025FY2026

Management fee income (AUD Mn)

25.030.335.4

Assets under management (AUD Bn)

4.55.25.9

Returns & Leverage Ratios and Margin Analysis (%)

MetricFY2025FY2026

Cash operating expenses (AUD Mn)

83.967.1

Cost coverage fee income over cash opex (%)

3653

New commitments (AUD Mn)

516.1712.2

New fair value added (AUD Mn)

525.9564.4

Cash investment proceeds excluding secondaries (AUD Mn)

235.5350.5

Permanent headcount

167156

Revenue by Region

MetricFY2025FY2026

Americas revenue from contracts with customers (AUD K)

7,56812,239

APAC revenue from contracts with customers (AUD K)

2,8028,732

EMEA revenue from contracts with customers (AUD K)

38,15371,613

Corporate revenue from contracts with customers (AUD K)

6,4633,728

Total revenue from contracts with customers (AUD K)

54,98696,312

Revenue by Region — EMEA claims portfolio revenue

MetricFY2025FY2026

EMEA claims portfolio revenue (AUD K)

34,53367,556

Americas claims portfolio revenue (AUD K)

01,419

Americas management service and transaction fees (AUD K)

7,56810,820

APAC management service and transaction fees (AUD K)

2,8028,732

EMEA management service and transaction fees (AUD K)

3,6204,057

Corporate management service and transaction fees (AUD K)

6,4633,728

Revenue by Region — Americas net gain on derecognition

MetricFY2025FY2026

Americas net gain on derecognition (AUD K)

6,9780

APAC net gain on derecognition (AUD K)

1,844295

EMEA net gain on derecognition (AUD K)

17,6776,742

Region Overview

RegionContract revenue YoYSegment PBT FY26Assessment

Americas

+62%

A$-27m

Fastest-growing fee base (fees +43%). Loss-making on allocation of costs and limited fair-value gains. Largest market for commercial litigation finance (US commitments US$2.8bn in 2025 per Westfleet).

APAC

+212%

A$66m

Fees tripled from a low base. Strong fair-value gains (A$79m). The class-action ecosystem remains supportive.

EMEA

+88%

A$38m

Largest revenue contributor. Driven by enforcement and claims-portfolio completions. Amortisation-heavy.

Corporate

-42%

A$-29m

Shrinking cost centre

Capital Markets

MeasureValueSource / date

Last verified close

A$1.40

18 Sep 2026 (S&P via StockAnalysis); A$1.47 intraday on 22 Sep 2026

52-week range

A$1.35 – A$1.895

StockAnalysis, Aug 2026

1-year change

-23.3%

52 weeks to ~19 Sep 2026 (S&P)

1-year change at results date

~-10%

12 months to 27 Aug 2026 (Motley Fool)

Fund 9 announcement reaction

~+40% (A$0.965 to ~A$1.35–1.385)

18 Dec 2024 (ShareCafe; Motley Fool)

5-year change

Market cap was ~A$954m in May 2022 (Simply Wall St) versus ~A$405m now, a fall of roughly 57% in capitalisation.

Approximate

Beta (5Y)

0.42

S&P

Per-Share Data and Share Count (M)

MetricFY2022FY2023FY2024FY2025FY2026

Basic EPS (AUD)

-0.17-0.12-0.311.23150.1858

Attributable book value per share (AUD)

1.221.250.892.322.34

Net assets per share including NCI (AUD)

2.752.812.812.992.96

Shares on issue (M)

268.64278.62282.55288.43289.64

Valuation Multiples

MultipleOBLBasis

P/E (trailing)

7.6x

S&P (attributable EPS A$0.1858)

P/B (total equity incl. NCI)

0.47x

S&P; versus company net assets per share A$2.96

P/B (attributable equity)

0.60x

Analyst: A$405.5m / A$676.6m

P/TBV

0.71x

S&P

Price / book value of investments per share

0.62x

Analyst: A$1.40 / A$2.25

EV/Sales

4.2x

S&P

EV/EBITDA

11.6x

S&P

Earnings yield

13.2%

S&P

Capital Instruments

InstrumentAmount (30 Jun 2026)MaturityRecourse

Fund 8 facility (borrowings)

A$35.4m carrying value; A$38.2m drawn

Not disclosed in extract

Non-recourse to the Group, except insurance, Fund 8 assets and a capped standby equity commitment

Lease liabilities

A$9.9m

Various

Group

Warrants (Ares)

A$29.5m fair-value liability (A$35m equivalent)

Exercisable from the 2nd to 5th anniversary of the transaction date

Expected equity settlement

Corporate debt

Nil

Repaid in FY25

—

Analyst Conclusions

Management guidance

Omni Bridgeway does not issue earnings guidance. Management's stated outlook is:

  • demand is expected to continue in all markets, with litigation funding viewed as non-cyclical and uncorrelated (FY26 AR);

  • the pipeline is elevated, at 43 term sheets worth an estimated A$407.8m, and terms on new commitments are improving;

  • the flagship fund programme is fully raised;

  • A$45.3m of proceeds was received after 30 June 2026 at ~5.7x MOIC;

  • the ambition is 70% cost coverage by 2028.

Consensus growth expectations are not available from verified sources.

Bull case

  1. Operating leverage plus carry. If fees rise from A$35m towards A$47m while opex stays near A$67m, cost coverage reaches 70%. Carried interest from Funds 6 and 4/5 (75% retained for shareholders) then adds a high-margin earnings stream on top of co-investment returns.

  2. Deep discount to book. At 0.60x attributable book and 0.62x book value of investments per share, the market implies large markdowns. Yet FY26 completions converted at 105% of fair value, and the Ares transaction cleared at a c.80% fair-value conversion. A secondary-market "mark" exists well above the current price.

  3. Record origination in a consolidating market. Commitments of A$712m (+38%) and a new US$1bn flagship position OBL as one of 12–15 funders driving the market (Westfleet). Supply-side exits improve pricing.

Bear case

  1. Earnings quality. FY26 statutory profit was smaller than the A$61.9m of unrealised and realised fair-value gains. 2H26 implied a statutory loss before NCI. Statutory OCF was negative (-A$18.3m). The market may continue to discount Level 3 valuations.

  2. FX and duration drag. AUD-reported values are exposed to USD and EUR moves (A$48.7m OCI loss in FY26). Court delays, as experienced industry-wide, can erode IRRs and delay carry.

  3. Scale and dilution. At a ~A$0.4bn market cap, OBL competes for capital and talent with multi-trillion-dollar managers. Ares warrants (A$35m equivalent) and new executive equity plans add dilution. The Executive Plan's 12.5% ROE hurdle highlights how far current returns (5–8%) are from management's own target.

Catalysts and monitorables (next 12 months)

CatalystExpected timingWhat to watch
2026 AGM (Executive Plan vote; CEO participation resolution)Late October 2026Vote outcome; any "strike" on remuneration
1Q27 Investment Portfolio ReportLate Oct / Nov 2026Proceeds, MOIC, commitments, pipeline conversion
Finalisation of >US$300m Series II subscriptionsFY27Fee-paying AUM growth
Ares warrant exercisability window opensFrom the 2nd anniversary of the transaction date (~Dec 2026 – Apr 2027)Exercise, dilution, strategic signal
1H27 results~Feb 2027Cost coverage trajectory towards 70%; cash carry; FX impact
Sidecar capital (~A$175m in diligence)FY27Structured-capital traction under the new NY leadership
Regulatory developments (UK PACCAR fix, EU TPLF, US disclosure and tax)OngoingAny adverse rule changes
Board renewalFY27Addition of independent directors

Concluding analyst verdict

Omni Bridgeway enters FY27 in the strongest corporate condition of its recent history.

  • It carries no corporate debt.

  • Its cost base is a fifth smaller than a year ago.

  • It holds a fully subscribed US$1bn flagship programme.

  • FY26 delivered record commitments and proceeds.

  • Its realised investment performance remains distinctive: a 2.3x MOIC and 105% fair-value conversion across 80 completions.

The Fund 9 transaction with Ares was strategically decisive. It repaired the balance sheet, demonstrated that sophisticated capital will pay near fair value for OBL-originated portfolios, and repositioned the company as a capital-light manager of legal assets.

The market's scepticism is nonetheless rational on three counts:

  1. Fee coverage. Statutory profitability still rests on fair-value accounting, and fee income covers only about half of operating costs.

  2. Cash flow. Reported operating cash flow is negative, and FX translation can erase a year's profit at the comprehensive-income level, as it did in FY26.

  3. Returns. Returns on attributable equity (≈8%) remain below both the 12% discount rate used to value the book and the 12.5% floor in management's own incentive plan.

The share price, near A$1.40 and roughly 0.6x attributable book, reflects those doubts more than it reflects the platform's realised track record.

The investment case therefore hinges on a measurable glide path. Evidence would be:

  • cost coverage moving from 53% towards the 70% target by 2028;

  • cash carried interest building from the A$6.6m base;

  • continued fair-value conversion at or above 100%; and

  • disciplined capital management, including potential buybacks at a deep discount to book once cash generation allows.

Execution in FY26 was credible on every target set. If FY27 shows similar delivery while the post-balance-date proceeds (A$45.3m at ~5.7x) and the A$407.8m pipeline convert, the discount to book should narrow.

Verdict: a fundamentally improved, under-valued but still "show-me" story. The key monitorables are cost coverage, cash carry and FX.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedEducationBackgroundOther listed boards (past 3 yrs)Independence

Michael Green

Non-Executive Director and Chairman

Apr 2023

BA (Hons) Economics, University of Exeter

20+ years in global investment management. International CEO of Morgan Stanley Investment Management and of American Century Investments. Co-opted member of London CIV Investment Oversight Committee (2020–23).

Chair and Independent Trustee, Lloyd's of London Pension Scheme (from May 2007)

Independent

Raymond van Hulst

Managing Director and CEO

Executive Director Apr 2020; CEO Oct 2023

MBA (INSEAD); Masters in Management (University of Groningen)

~25 years in legal finance. At Omni Bridgeway since 2002. Established six institutionally backed funds, including the IFC DARP JV and the Ares continuation fund. Led the ROLAND acquisition (2017) and the IMF Bentham–Omni merger (2019). Previously ABN AMRO Structured Finance (India and Europe).

Nil

Executive

Karen Phin

Non-Executive Director; Chair of Nomination & Remuneration Committee

Aug 2017

BA, LLB (Hons), University of Sydney; FAICD

25+ years in capital markets advisory. MD and Head of Capital Advisory, Citigroup ANZ. MD at UBS (13 years). Senior Specialist at ASIC.

NED ARB Corporation (from Jun 2019); NED Supply Network (from Sep 2025); Takeovers Panel member (since 2015)

Independent

Christine Feldmanis

Non-Executive Director

Nov 2018

BCom (Wollongong); Master of Applied Finance (Macquarie); FAICD; CPA; F Fin

30+ years in finance and investment. Former MD of an ASX-listed boutique funds-management incubator. Former CFO, NSW Treasury Corporation.

NED Bell Financial Group (from Feb 2020); NED United Malt (Jan–Nov 2023)

Independent

Directors' Remuneration

BodyMeetings held

Board

10

Audit & Risk Committee

4

Nomination & Remuneration Committee

6

Corporate Governance Committee

4

Executive Leadership Team

NameTitleSinceBackground

Raymond van Hulst

MD & CEO

CEO Oct 2023

See above

David Breeney

Global CFO

1 Mar 2025

12+ years at Challenger Ltd in senior finance roles. Joined OBL 2023 as Global Head of Financial Control; Deputy CFO Oct 2024. BA (Hons) Economics (UWE); FCA (ICAEW); CA ANZ.

Jeremy Sambrook

Global General Counsel & Company Secretary

18 Jan 2016

Corporate lawyer (UK, Hong Kong, Channel Islands, Australia); LLB (Bristol)

Peter Galgay

Head of Commercial Strategy & Capital Solutions (New York)

Apr 2026

Focus on large-scale structured finance and alternative investment solutions for legal assets (not KMP)

Nathan Kandapper

Global Head of Investor Relations

—

(not KMP)

Executive Leadership Team (Annual)

NameCurrencySalary & feesCash bonusSuper/pensionEmployee entitlementsShare performance rightsTotal FY26Total FY25Performance-related % FY26

R. van Hulst

CHF

701,876048,10616,246293,0851,059,313874,81828%

D. Breeney

AUD

450,000030,00013,534135,923629,457

216,770 (part-year)

22%

J. Sambrook

AUD

485,800030,000-560337,587852,827832,77040%

M. Green

GBP

75,000000075,00075,0000%

K. Phin

AUD

120,536014,46400135,000135,0000%

C. Feldmanis

AUD

135,0000000135,000135,0000%

Major Shareholders

HolderShares

R. van Hulst

6,355,129

M. Green

207,115

C. Feldmanis

135,000

K. Phin

102,266

J. Sambrook

8,446

D. Breeney

0

KMP total

6,807,956 (≈2.4% of 289.6m)

Major Shareholders — Perpetual Limited

HolderStakeDate / sourceStatus

Perpetual Limited (incl. TSW)

13.657% (39.39m shares), with further purchases of ~5.48m shares reported to 31 Oct 2025

Form 604, 23 Oct 2025 (FilingReader); Simply Wall St

—

Retail Employees Superannuation Trust (REST)

~9.5%

Simply Wall St, Sep 2024

—

Samuel Terry Asset Management

~5.8% (Sep 2024); bought a further 3.8m shares in Jun 2025

Simply Wall St

—

Brightlight Capital

Became substantial 16 Apr 2026; ceased 16 Jul 2026

Form 605 (Kalkine)

Exited substantial

Amitell Capital

Sold ~2.0m shares, Sep 2025

Simply Wall St

Reduced

Ares Management

Warrants equivalent to A$35m; not yet exercisable

FY26 AR

Potential holder

R. van Hulst

~2.2%

FY26 AR

Insider

Competitive Landscape

Key Competitors

CompetitorListingSegment overlapScale indicatorPositioning vs OBL

Burford Capital

NYSE / LSE: BUR

Global commercial litigation, asset management, enforcement, monetisation

FY25 (USD): new definitive commitments US$872m (+39%); consolidated capital provision income US$477m; consolidated net income US$72m; consolidated cash receipts US$770m; cash and securities US$656m (Burford DEF 14A, 2026)

Largest peer; balance-sheet-heavy with bond funding; higher US concentration and large YPF exposure

Litigation Capital Management (LCM)

AIM: LIT

APAC and UK commercial, class actions, arbitration

—

Smaller; Australian heritage; direct competitor in APAC class actions

Harbour Litigation Funding

Private (UK)

UK and European commercial

—

Major UK competitor

Therium Capital Management

Private (UK)

UK, international commercial and arbitration

——

Fortress Investment Group (legal assets)

Private (Mubadala-owned)

US, global legal assets, IP

—

Deep-pocketed multi-strategy entrant

Parabellum Capital

Private (US)

US commercial and IP

—

US portfolio funder

Longford Capital

Private (US)

US commercial; law-firm financing

—

US competitor

Bench Walk Advisors

Private (US)

US and global commercial

—

US competitor

CASL (Litigation Lending Services and peers)

Private (Australia)

Australian class actions

—

APAC class-action competitor

Woodsford

Private (UK)

UK and EU collective actions

—

EU/UK collective-action competitor

Deminor

Private (Belgium)

EU litigation funding, enforcement and recovery

—

Competes in EMEA enforcement and recovery

Nivalion

Private (Switzerland)

DACH and EU litigation funding

—

EMEA competitor

Augusta Ventures

Private (UK)

UK, international commercial

—

UK competitor

“—” = not publicly disclosed.

Peer Comparison FY2026

MetricOmni Bridgeway (FY26, A$)Burford Capital (FY25, US$)

New commitments

A$712.2m (+38%)

US$872m (+39%)

Investment proceeds / cash receipts

A$350.5m (consolidated)

US$770m (consolidated)

Fee income

A$35.4m (+17%)

—

Statutory net income

A$45.9m (attributable A$53.7m)

US$72m consolidated

Corporate leverage

Net cash; no corporate debt

US$500m 7.50% notes due 2033 issued Jul 2025; ~0.9x debt/net tangible equity (3Q25)

AUM

A$5.9bn

—

Recent Developments

*Litigation and regulatory actions against

*Layoffs: headcount fell from 167 to 156 in FY26.

Company Snapshot

156

Employees

1986

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Realised track record. FY26: 80 completions, 2.3x MOIC, 105% fair-value conversion. 1H26: five-year trailing IRR of 40% (FY26 results; Quartr summary).
  • Debt-free corporate balance sheet. Corporate debt of A$250m was repaid in FY25. The only borrowings are the Fund 8 facility (A$35.4m, non-recourse) (FY26 AR Note 19).
  • Third-party capital validation. Ares paid ~A$320m (day-1 MOIC >3x). The US$1bn Funds 4/5 Series II target was achieved, with A$862m of new third-party capital added in FY26.
  • Cost discipline. Cash opex of A$67.1m was 16% below budget and 20% below FY25. Employee costs fell 16% (FY26 AR).
  • Record origination. A$712.2m of commitments across 43 investments (+38%), with a A$407.8m term-sheet pipeline at 30 June 2026 (4Q26 report).
  • Unique enforcement franchise. EMEA claims-portfolio revenue was A$67.6m in FY26 (FY25: A$34.5m). Chambers Band 1 Global Asset Tracing & Recovery (2020–2025).
  • Global diversification. More than 300 active investments across 15 countries (FY26 AR).

Weaknesses

  • Fee income does not cover costs. Cost coverage is 53% (A$35.4m fees against A$67.1m opex).
  • Statutory earnings depend on fair value. The FY26 net FVTPL gain of A$61.9m exceeded profit before tax of A$48.2m. 2H26 implied a pre-NCI statutory loss of ~A$38.6m.
  • Negative statutory operating cash flow. OCF was -A$18.3m in FY26, and -A$74.6m to -A$130.4m in FY22–FY24.
  • FX exposure. The FY26 OCI loss was A$48.7m; total comprehensive income was -A$2.8m.
  • Complex reporting. Multiple book-value definitions (A$2.96 vs A$2.34 attributable vs A$2.25 investments vs A$2.08 NTA). The non-IFRS bridge requires adjustments of A$244.9m for third-party interests.
  • Americas loss. Segment PBT of -A$27m in FY26, despite the US being the largest market.
  • Small board. Only four directors, with no new director since 2023 (Simply Wall St).

Opportunities

  • Operating leverage from scale. The 70% cost-coverage target by 2028 implies fees approaching ~A$47m at FY26 opex.
  • Carried interest ramp. Funds 6 and 4/5 Series I and II carry a 75% shareholder share. Cash carry was A$6.6m in FY26, the start of the curve.
  • Repeatable secondaries and continuation funds. The Fund 9 template could be used for future portfolios.
  • Structured capital and sidecars. ~A$175m in diligence; the New York capital-solutions build-out.
  • US market recovery. US commitments rose 23% in 2025 (Westfleet). Clients increasingly deal directly with funders (52% client-directed).
  • Industry consolidation. Fewer, larger platforms; favourable pricing ("improving terms on new commitments," CEO, FY26).

Threats

  • Regulation. UK PACCAR aftermath; EU regulatory proposals; renewed US tax or disclosure proposals.
  • Duration and court delays. Lower IRRs and delayed realisations; peer Burford cited duration-driven unrealised losses in 2025.
  • Concentration risk in large matters. Flagged in the FY26 AR. Several "legally successful" large matters had not converted to cash in 3Q26.
  • Competition from multi-strategy managers. Fortress, and potentially Ares directly.
  • Warrant dilution. A$35m-equivalent warrants exercisable from the second anniversary of the transaction date.
  • Key-person risk. CEO van Hulst architected the funds and the Ares deal. The FY26 AR flags people risk.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
17 Mar 2025David Breeney confirmed as Global CFO (effective 1 Mar); capital formation team created; Leger departsFinance centralised in Sydney; fundraising capability built
15 Apr 2025Fund 9 completion; final A$45m received; total ~A$320mTransformational deleveraging
Apr 20253Q25 portfolio report: on track for FY25 opex target of A$85mCost discipline signalled
7 May 2025Chairman Green buys 134,903 shares at ~A$1.62Insider confidence
8 May 2025Perpetual sells ~2.4m shares (later re-accumulates)Register churn
23 Jun 2025Samuel Terry Asset Management buys ~3.8m shares (~A$1.15)Value-investor support
Jul 2025US federal tax package enacted without a litigation-funding tax, which OBL had flagged as a riskRemoves a major US regulatory overhang
28 Aug 2025FY25 results: total income A$651.2m; NPAT A$416.8m; attributable A$349.8m; EPS A$1.23; fees A$30.3m; AUM A$5.2bn; net cashRecord statutory result (one-off)
4 Sep 2025Thompson, Siegel & Walmsley sells 317,100 sharesMinor
11–12 Sep 2025Amitell Capital sells ~2.0m sharesOverhang reduced
Sep 2025Director Phin joins Supply Network boardGovernance (minor)
23 Oct 2025Perpetual raises stake to 13.657%Largest holder increases position
28 Oct 20252025 AGM: Chairman's and CEO's addressesStrategy reaffirmed
31 Oct 2025Perpetual buys a further ~5.48m shares (~A$1.62)Continued accumulation
4 Nov 2025799,259 shares issued on FY23 LTIP vestingMinor dilution
1H26Additional US$228m closed for Funds 4/5 Series IIFlagship fundraising progress
9 Feb 20262Q26 portfolio update ("excellent completion metrics")Positive operating data
25 Feb 20261H26 results: total income A$179.5m; NPAT A$84.5m; EPS A$0.29; 45 completions at 2.6x MOIC; proceeds A$223.7m; fees +37%; AUM A$5.5bn; book value per share A$3.20Strong half; 70% cost-coverage-by-2028 ambition referenced
26 Mar 2026Introduction to Omni Bridgeway and Analyst Data Pack releasedInvestor-relations transparency
1 Apr 2026Peter Galgay appointed Head of Commercial Strategy & Capital Solutions (New York)US structured-capital push
7 Apr 2026CEO buys ~36k shares at ~A$1.59; 410,221 employee-plan shares issuedInsider confidence
16 Apr 2026Brightlight Capital becomes substantial holderRegister change
29–30 Apr 20263Q26 report: 59 completions FYTD at 2.5x MOIC; pipeline of 45 term sheets (~A$618.9m), over 2x averagePipeline surge
1 May 2026Third-party governance flag: no board additions since 2023Governance watch item
16 Jul 2026Brightlight ceases to be substantial holder; FY26 results date setRegister change
30–31 Jul 20264Q26 report: record A$712.2m commitments (A$343.0m in June quarter); record A$350.5m proceeds; post-30 June proceeds A$45.3m at ~5.7xRecord activity
27 Aug 2026FY26 results: NPAT A$45.9m (attributable A$53.7m); EPS 18.58c; no dividend; US$1bn Series II target achieved; opex A$67.1m; cost coverage 53%Clean "execution year"; share price eased
27 Aug 2026Remuneration overhaul: Team Carried Interest Plan live; Executive Plan to go to the 2026 AGMGovernance catalyst
Sep 2026Shares trade around A$1.40–1.47, near the 52-week low (A$1.35); about -23% over 52 weeks (S&P)De-rating despite record operations
Oct 2026 (expected)2026 AGM, including the Executive Plan vote; 1Q27 portfolio report expected late Oct/early Nov–

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

8 charts
Income Statement: Revenue & Gross Profit: Total gross revenue fell from AUD 593.7 Mn in FY2025 to AUD 388.3 Mn in FY2026.
Omni Bridgeway Ltd — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2025FY2026
Total gross revenue593.7388.3
Interest revenue and other33.22.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.